Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Onconetix (ONCO) EBITDA Margin (2023 - 2025)

Onconetix (ONCO) has disclosed EBITDA Margin for 2 consecutive years, with 13357.93% as the latest value for Q4 2024.

  • On a quarterly basis, EBITDA Margin rose 276559.0% to 13357.93% in Q4 2024 year-over-year; TTM through Dec 2024 was 4079.53%, a 1007755.0% decrease, with the full-year FY2024 number at 7303.98%, up 6721807.0% from a year prior.
  • EBITDA Margin was 13357.93% for Q4 2024 at Onconetix, up from 107.14% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 13357.93% in Q4 2024 to a low of 176262.79% in Q1 2023.